Genetic variation can affect drug efficacy and likelihood of the occurrence of an adverse drug reaction. Our WPS test includes both common and rare variants, especially the ethnicity-specific variants, in order to generate accurate and ethnicity-inclusive test results and actionable interpretation*.

WPS was developed from a highly comprehensive PGx assay that analyzes 4,627 markers within nearly 1,200 genes¹. Due to the large scope of the test, the haplotype/allele information will be added to the list in phases. If the genes or markers you are interested in are not shown in the list, please contact us or email info@rprdx.com directly for more information.

*Haplotypes represented by mutations not present in the test are considered wild type, which for many (but not all) genes are reported as a *1 allele. The presence of other variants that are not detected in the assay may influence drug metabolism. All relevant patient information must be considered when making any dosing decision. Please contact us for additional information on haplotypes reported on the WPS assay.

“available upon request” indicates the specific variant is not interpreted in the clinical report, but is investigated by the assay and can be made available upon request. Please contact us if you would like to receive the test results of these variants prior to ordering the test.